New drug cocktail shows promise for pancreatic cancer before surgery
NCT ID NCT03483038
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 24 times
Summary
This study tests a combination of three chemotherapy drugs (liposomal irinotecan, 5-FU, and oxaliplatin) given before surgery to people with pancreatic cancer that can be removed. The goal is to see if this approach is safe and helps reduce complications after surgery. About 45 adults with early-stage pancreatic cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Orlando Health UF Health Cancer Center
Orlando, Florida, 32806, United States
-
Tallahassee Memorial Health Care
Tallahassee, Florida, 32308, United States
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.